Abstract
AbstractStructure‐based design usually focuses upon the optimization of ligand affinity. However, successful drug design also requires the optimization of many other properties. The primary source of structural information for protein–ligand complexes is X‐ray crystallography. The uncertainties introduced during the derivation of an atomic model from the experimentally observed electron density data are not always appreciated. Uncertainties in the atomic model can have significant consequences when this model is subsequently used as the basis of manual design, docking, scoring, and virtual screening efforts. Docking and scoring algorithms are currently imperfect. A good correlation between observed and calculated binding affinities is usually only observed only when very large ranges of affinity are considered. Errors in the correlation often exceed the range of affinities commonly encountered during lead optimization. Some structure‐based design approaches now involve screening libraries by using technologies based on NMR spectroscopy and X‐ray crystallography to discover small polar templates, which are used for further optimization. Such compounds are defined as leadlike and are also sought by more traditional high‐throughput screening technologies. Structure‐based design and HTS technologies show important complementarity and a degree of convergence.
References
137
Referenced
315
10.1107/S0108767390010224
10.1107/S0907444998003254
{'key': 'e_1_2_9_3_2', 'volume-title': 'X‐PLOR. A System for Crystallography and NMR”', 'author': 'Brünger A. T.', 'year': '1990'}
/ X‐PLOR. A System for Crystallography and NMR” by Brünger A. T. (1990)10.1107/S0907444994003112
/ Acta Crystallogr. Sect. D by 4 Collaborative Computational Project Number (1994)10.1146/annurev.biophys.29.1.291
10.1007/BF00124402
10.1006/jmbi.1996.0477
10.1006/jmbi.1996.0897
10.1021/jm00145a002
10.1002/prot.340110104
10.1107/S0907444998007124
10.1006/jmbi.1999.2809
10.1007/BF00126743
/ J. Comput. ‐Aided. Mol. Des. by Bohm H. J. (1994)10.1006/jmbi.1999.3371
10.1021/jm0105833
10.1007/BF02174464
10.1021/ja00226a005
10.1002/qsar.19930120103
- LEAPFROG Tripos Inc. 1699 South Hanley Rd. St Louis MO 63144 USA.
10.1021/ar970146b
10.1021/ci00017a027
- UNITY 4.2.1 Tripos Inc. 1699 South Hanley Rd. St Louis MO 63144 USA.
10.1002/(SICI)1097-0134(19981001)33:1<74::AID-PROT7>3.0.CO;2-L
10.1126/science.274.5292.1531
10.1016/S1074-5521(00)80022-8
10.1038/80319
10.1038/nrd706
10.1038/314235a0
10.1073/pnas.90.4.1172
10.1023/A:1008708418253
10.1016/S0169-409X(96)00423-1
10.1021/jm970666c
- http://setiathome.ssl.berkeley.edu/.
- http://www.chem.ox.ac.uk/curecancer.html.
10.1007/978-3-662-04383-7_1
10.1016/S0065-7743(08)60591-6
10.1016/S1359-6446(01)02091-8
10.1021/cr960370z
{'key': 'e_1_2_9_39_2', 'first-page': '137', 'volume-title': 'Methods and Principles in Medicinal Chemistry Volume 14 Bioinformatics—From Genome to Drug', 'author': 'Stahl M.', 'year': '2002'}
/ Methods and Principles in Medicinal Chemistry Volume 14 Bioinformatics—From Genome to Drug by Stahl M. (2002)10.1021/jm010425b
10.1124/mol.59.4.806
10.1016/S0169-409X(99)00027-7
10.1358/dof.1998.023.09.473829
10.1016/S1074-5521(98)90117-X
10.1358/dof.1998.023.09.858365
10.1038/363418a0
- Physicians' Desk Reference 55. edition Thomson Medical Economics Montvale 2001 p. 1454.
10.1021/ja963036t
- R&D Insight 2000 ADIS International Ltd. Chester United Kingdom.
10.1016/S0021-9258(18)90804-5
/ J. Biol. Chem. by Navia M. A. (1984)10.1126/science.2493678
10.1016/1359-6446(96)10020-9
10.1016/S1074-5521(99)89004-8
10.3109/10799899909036635
10.1021/jm00034a001
10.1007/0-306-47384-4_24
10.1038/nsb0695-458
10.1016/S1388-1981(99)00157-2
10.1007/978-1-4757-2335-9
10.1016/S0076-6879(97)77012-5
10.1016/S0076-6879(97)77013-7
10.1016/S0022-2836(77)80200-3
- http://www.rcsb.org/pdb.
10.1107/S0907444999016364
{'key': 'e_1_2_9_66_2', 'first-page': '11', 'volume-title': 'Making the Most of Your Model', 'author': 'Kleywegt G. J.', 'year': '1995'}
/ Making the Most of Your Model by Kleywegt G. J. (1995)10.1038/343687a0
10.1021/ja005533m
10.1021/ja025109g
10.1038/355472a0
10.1016/S0969-2126(01)00187-3
10.1016/S0076-6879(97)77021-6
10.1016/S0969-2126(96)00097-4
10.1038/381272a0
- http://www.cmbi.kun.nl/gv/pdbreport.
- J. Y. Zou M. R. Harris T. Taylor A. Wählby G. J. Kleywegt T. A. Jones unpublished results.
10.1126/science.3775366
10.1126/science.1069556
10.1016/S0969-2126(94)00125-1
{'key': 'e_1_2_9_80_2', 'first-page': '155', 'volume-title': 'Enzyme Structure and Mechanism', 'author': 'Fersht A.', 'year': '1985'}
/ Enzyme Structure and Mechanism by Fersht A. (1985)10.1007/978-1-4615-4141-7_11
10.1002/1439-7633(20020301)3:2/3<246::AID-CBIC246>3.0.CO;2-#
10.1016/S0969-2126(01)00261-1
10.1002/pro.5560050408
10.1042/bj3460201
10.1006/jmbi.1998.1931
10.1016/S0969-2126(97)00222-0
10.1093/protein/9.12.1083
-
“Options for the Control of Influenza IV”: A. Harris F. Forouhar S. Qiu S. Shihong L. M. Bingdong Int. Congress Series 2001 1219 405–410.
(
10.1016/S0531-5131(01)00349-1
) 10.1107/S0907444901021758
10.1107/S090744499300808X
10.1107/S0907444994002659
10.1107/S0907444994003021
10.1016/S1074-5521(96)90164-7
10.1023/A:1015930826903
10.1107/S0907444998007100
- http:// xray.bmc.uu.se/hicup.
10.1007/BF00355047
10.1016/S0021-9258(19)74325-7
/ J. Biol. Chem. by Eads J. (1993)10.1074/jbc.272.11.7140
10.1021/bi00054a019
10.1002/prot.10232
10.1002/1521-1878(200011)22:11<1024::AID-BIES9>3.0.CO;2-W
- http://www.expasy.ch/spdbv.
10.1016/S0969-2126(02)00743-8
- http://fsrv1.bmc.uu.se/eds.
- http://xray.bmc.uu.se/embo2001/modval.
10.1021/bi00057a028
10.1021/bi0107400
10.1002/pro.5560071002
- http://www.ccdc.cam.ac.uk/prods/gold/value.html.
10.1023/A:1008015827877
10.1021/ar00028a003
10.1021/cr9400976
10.1039/a827057z
10.1021/bi00368a028
10.1021/jm980536j
{'key': 'e_1_2_9_118_2', 'first-page': '445', 'volume': '9', 'author': 'Bohm H.‐J.', 'year': '1999', 'journal-title': 'Med. Chem. Res.'}
/ Med. Chem. Res. by Bohm H.‐J. (1999)10.1021/ja9539002
10.1023/A:1027299602978
10.1021/jm00002a012
10.1002/(SICI)1521-3757(19990315)111:6<778::AID-ANGE778>3.0.CO;2-C
10.1002/(SICI)1521-3773(19990315)38:6<736::AID-ANIE736>3.0.CO;2-R
10.1002/(SICI)1097-0134(20000515)39:3<261::AID-PROT90>3.0.CO;2-4
{'key': 'e_1_2_9_124_2', 'first-page': '215', 'volume': '42', 'author': 'Goodford P.', 'year': '1998', 'journal-title': 'Alfred Benzon Symp.'}
/ Alfred Benzon Symp. by Goodford P. (1998)10.1023/A:1008737207775
10.1016/S1074-5521(01)00023-0
10.1021/ja003972f
10.1021/ja960897t
10.1002/(SICI)1521-3757(19991216)111:24<3962::AID-ANGE3962>3.0.CO;2-8
10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U
10.1021/ci010366a
10.1021/ci000403i
10.1016/S0969-2126(98)00086-0
10.1021/jm010548w
10.1021/jm010944e
10.1016/S1074-5521(97)90073-9
Dates
Type | When |
---|---|
Created | 22 years, 2 months ago (June 18, 2003, 6:13 a.m.) |
Deposited | 1 year, 10 months ago (Oct. 11, 2023, 5:10 p.m.) |
Indexed | 3 weeks, 5 days ago (July 30, 2025, 10:45 a.m.) |
Issued | 22 years, 2 months ago (June 17, 2003) |
Published | 22 years, 2 months ago (June 17, 2003) |
Published Online | 22 years, 2 months ago (June 17, 2003) |
Published Print | 22 years, 2 months ago (June 23, 2003) |
@article{Davis_2003, title={Application and Limitations of X‐ray Crystallographic Data in Structure‐Based Ligand and Drug Design}, volume={42}, ISSN={1521-3773}, url={http://dx.doi.org/10.1002/anie.200200539}, DOI={10.1002/anie.200200539}, number={24}, journal={Angewandte Chemie International Edition}, publisher={Wiley}, author={Davis, Andrew M. and Teague, Simon J. and Kleywegt, Gerard J.}, year={2003}, month=jun, pages={2718–2736} }